Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2004
07/15/2004WO2003047513A3 Method for treating ocular hypertension
07/15/2004WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor
07/15/2004WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
07/15/2004WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor
07/15/2004WO2003037345A9 Pharmaceutical formulations comprising substituted xanthine compounds
07/15/2004WO2003000172A3 Methods, pharmaceutical compositions, oral compositions, filters and tobacco products for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject
07/15/2004WO2002024216A3 Method for use of igf-binding protein for selective sensitization of target cells in vivo
07/15/2004WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response
07/15/2004US20040138739 Method of reducing thrombosis and complications after arterial angioplasty using stent coated with magnesium-based compound
07/15/2004US20040138502 Ph-dependent nmda receptor antagonists
07/15/2004US20040138486 Steroid with cyclohexene and oxidized unsaturated ketone oxidized with copper iodide and tert-butyl hydroperoxide
07/15/2004US20040138462 Aminoalcohol derivatives
07/15/2004US20040138459 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
07/15/2004US20040138454 Drugs for treating pain formed by arylation
07/15/2004US20040138449 Antiviral agents
07/15/2004US20040138446 Biotin derivative with ether, amide or amine group for detection of drug interactions.
07/15/2004US20040138437 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
07/15/2004US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth
07/15/2004US20040138425 Site-specific aminoglycoside derivatives for use in immunodiagnostic assays
07/15/2004US20040138415 Helicobacter proteins, nucleic acids and uses thereof
07/15/2004US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media
07/15/2004US20040138315 Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
07/15/2004US20040138314 Reduction of breast density with 4-hydroxy tamoxifen
07/15/2004US20040138312 use of alpha 2 adrenergic receptor-selective agonists to prevent nerve cell damage and death, such as that observed in Parkinson's disease and Alzheimer's disease
07/15/2004US20040138311 medicament enables disturbances of thiol-disulfide status or those that occur, for example, in diabetes melltus to be treated simultaneously, separately or in a temporally graduated manner
07/15/2004US20040138308 use of a chloride channel opener, especially a prostaglandin compound for the treatment of gastrointestinal disorders; for example, 13,14-dihydro-15-keto-16-mono or dihalogen-prostaglandin compound
07/15/2004US20040138307 Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticals
07/15/2004US20040138306 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
07/15/2004US20040138305 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
07/15/2004US20040138304 Prodrugs of excitatory amino acids
07/15/2004US20040138303 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone
07/15/2004US20040138302 Antifungal antibiotics
07/15/2004US20040138301 Chemical uncouplers for the treatment of obesity
07/15/2004US20040138300 Compounds
07/15/2004US20040138299 Dispersion of bicalutamide for prostate cancer treatment
07/15/2004US20040138298 NMDA receptor antagonist formulation with reduced neurotoxicity
07/15/2004US20040138297 Administering bicyclic diterpene compound of the labdane to treat menstrual disorders and premenstrual syndrome
07/15/2004US20040138296 Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease
07/15/2004US20040138293 Pharmaceutical composition made of cannabis extracts
07/15/2004US20040138291 Hypotensive therapy; administering angiotensin converting enzyme ( ACE) inhibitor such as enalapril, and dopaminergic agonist apomorphine or salt or ester thereof
07/15/2004US20040138290 Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium
07/15/2004US20040138289 Quaternary ammonium compounds
07/15/2004US20040138288 Anticancer compounds
07/15/2004US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
07/15/2004US20040138285 Low molecular weight compound and MEK1 inhibitor; bone disorders; osteoarthritis, arthritis
07/15/2004US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
07/15/2004US20040138281 Parkinson's and Huntington's disease; psychoses, impotence, renal or heart failure, schizophrenia
07/15/2004US20040138278 Administering an angiontensin type 1 (AT1)receptor antagonist such as eprosartan
07/15/2004US20040138277 Syndrome X, hyperglycemia, hyperlipidemia, obesity, atherosclerosis; anticoagulant, hypotensive, and antidiabetic agents; cardiovascular disorders
07/15/2004US20040138276 Metalloproteinase inhibitors
07/15/2004US20040138274 Novel pharmaceuticals
07/15/2004US20040138271 Benzene compound and salt thereof
07/15/2004US20040138270 Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
07/15/2004US20040138267 Antitumor agents
07/15/2004US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
07/15/2004US20040138263 Pharmaceutical compositions and dosage forms of thalidomide
07/15/2004US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
07/15/2004US20040138259 Pain management
07/15/2004US20040138258 Inhibitors of 11beta-hydroxysteroid dehydrogenase and uses therefor
07/15/2004US20040138257 Chemical derivatives and their application as antitelomerase agent
07/15/2004US20040138256 Process for the preparation of imidazole compounds
07/15/2004US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis
07/15/2004US20040138252 Pharmaceutical composition for therapy of interstitial cystitis
07/15/2004US20040138250 Inhibitors of cruzipain and other cysteine proteases
07/15/2004US20040138249 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
07/15/2004US20040138247 Use of desloratadine for treating allergic and inflammatory conditions
07/15/2004US20040138246 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment
07/15/2004US20040138245 Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
07/15/2004US20040138243 Antiinflammatory agents; asthma; Alzheimer's disease; Aids; antidiabetic agents; inflmamtory bowel disorders; anticholesterol agents; antitumor agenst
07/15/2004US20040138241 Urogenital disorders; benign protatic hyperplasia
07/15/2004US20040138240 Antitumor agents
07/15/2004US20040138239 Compositions and methods for targeting cerebral circulation and treatment of headache
07/15/2004US20040138237 Novel injectable depot formulations
07/15/2004US20040138235 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
07/15/2004US20040138233 Novel urokinase inhibitors
07/15/2004US20040138231 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropyl-methylcellulose phthalate polymer
07/15/2004US20040138228 Novel compounds with analgesic effect
07/15/2004US20040138226 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia
07/15/2004US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries
07/15/2004US20040138222 Post-trauma stress disorder, attention deficit disorders, obsessive compulsive disorders; anxiolytic agents; eating disorders; premenstrual disordrers
07/15/2004US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics
07/15/2004US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/15/2004US20040138218 Antitumor agents; antidiabetic agents; anticarcinogenic agents
07/15/2004US20040138212 Disubstituted 1,7-guanines
07/15/2004US20040138211 Antidiabetic agents; hypotensive agents; insulin resistance; antilipemic agents; cardiovascular disorders ; anticholesterol agents
07/15/2004US20040138210 Method of increasing neutrophil production using 2,3-benzodiazepines
07/15/2004US20040138209 Block sensitivity to leukotrienes; inflammatory bowel disorders; psoriasis; antiarthritic agents
07/15/2004US20040138208 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders
07/15/2004US20040138207 Antitumor agents
07/15/2004US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same
07/15/2004US20040138205 Viricides; hepatitis virus
07/15/2004US20040138204 Prevent binding of nerve cells to glutamate receptors using antagonist
07/15/2004US20040138203 Antiserotonine agents
07/15/2004US20040138202 Tetracyclic azepinoindole compounds
07/15/2004US20040138201 Prevent forming deposits of amyloid protein on nervous systems; Alzheimer's disease; Down syndrome
07/15/2004US20040138200 Pharmaceutical compositions for treatment of Parkinson's disease
07/15/2004US20040138199 Antiinflammatory agents; cardiovascular disorders; anticancer agents
07/15/2004US20040138198 Vasectomy procedure and related kit
07/15/2004US20040138197 Therapeutic use of aryl amino acid derivatives
07/15/2004US20040138196 Salinosporamides and methods for use thereof